April 30, 2009— Medicis and Ipsen today announced the U.S. FDA approval of the Biologics License Application (BLA) for DYSPORTTM (abobotulinumtoxinA), an acetylcholine release inhibitor and a neuromuscular blocking agent.
The details can be read here.
No comments:
Post a Comment